Scientific article

Corticostéroïdes et glaucome

Published inRevue médicale suisse, vol. 19, no. 820, p. 643-647
Publication date2023-03-29

Corticosteroid use is a major risk factor in the development of glaucoma and its aggravation. This is due to the augmentation of the intraocular pressure (IOP) induced by the corticoids. This augmentation is different between individuals: we called it steroid responsiveness, for which multiple risk factors have been identified, the most important being personal or family history of primary open angle glaucoma. The secondary augmentation of IOP depends also on the type of preparation, the mode of administration, the dosage and the duration of the therapy. Prevention and management are essentials to avoid this adverse effect. Among the most important measures, there are the education of the patient and the practitioner, IOP follow-ups after the use of corticoids and IOP-lowering medications.

  • Adrenal Cortex Hormones / adverse effects
  • Glaucoma / chemically induced
  • Glaucoma / drug therapy
  • Glaucoma, Open-Angle / drug therapy
  • Humans
  • Intraocular Pressure
  • Tonometry, Ocular
Citation (ISO format)
ABOUZEID, Hana, SINTZOFF, Lara. Corticostéroïdes et glaucome. In: Revue médicale suisse, 2023, vol. 19, n° 820, p. 643–647. doi: 10.53738/REVMED.2023.19.820.643
Main files (1)
Article (Published version)
accessLevelRestrictedaccessLevelPublic 09/30/2024
ISSN of the journal1660-9379

Technical informations

Creation05/15/2023 1:26:36 PM
First validation07/28/2023 11:32:34 AM
Update time07/28/2023 11:32:34 AM
Status update07/28/2023 11:32:34 AM
Last indexation01/18/2024 12:29:55 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack